Literature DB >> 11005797

The 22q11 deletion syndromes.

P J Scambler1.   

Abstract

DiGeorge syndrome, velocardiofacial syndrome and various other malformations have been described in association with deletions and translocations involving human chromosome 22q11. Many of the structural malformations observed are also seen in animal models of neural crest disruption suggesting that the haplo-insufficiency resulting from the deletion somehow affects this group of cells or their interactions. Over the past few years it has been shown that the deletion predisposes to a range of psychotic conditions prompting the hypothesis that the deleted region may contain a predisposition locus for psychotic illness. The DiGeorge chromosomal region has been entirely sequenced and many of the genes mapping to the deletion interval have been studied in some detail. Despite these efforts, no gene has yet been proved to play a defined role in the pathogenesis of the syndrome. Current efforts are directed at the study of engineered chromosome mouse models which offer the potential to dissect at least some of the developmental pathways disrupted in this intriguing group of malformation syndromes.

Entities:  

Mesh:

Year:  2000        PMID: 11005797     DOI: 10.1093/hmg/9.16.2421

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  151 in total

Review 1.  Science, medicine, and the future: Genetics and cardiovascular risk.

Authors:  I N Day; D I Wilson
Journal:  BMJ       Date:  2001-12-15

2.  Evidence for altered hippocampal function in a mouse model of the human 22q11.2 microdeletion.

Authors:  Liam J Drew; Kimberly L Stark; Karine Fénelon; Maria Karayiorgou; Amy B Macdermott; Joseph A Gogos
Journal:  Mol Cell Neurosci       Date:  2011-05-24       Impact factor: 4.314

Review 3.  Building a heart: implications for congenital heart disease.

Authors:  Deepak Srivastava
Journal:  J Nucl Cardiol       Date:  2003 Jan-Feb       Impact factor: 5.952

Review 4.  Genetic abnormalities of chromosome 22 and the development of psychosis.

Authors:  Nigel M Williams; Michael J Owen
Journal:  Curr Psychiatry Rep       Date:  2004-06       Impact factor: 5.285

Review 5.  The 22q11.2 microdeletion: fifteen years of insights into the genetic and neural complexity of psychiatric disorders.

Authors:  Liam J Drew; Gregg W Crabtree; Sander Markx; Kimberly L Stark; Florence Chaverneff; Bin Xu; Jun Mukai; Karine Fenelon; Pei-Ken Hsu; Joseph A Gogos; Maria Karayiorgou
Journal:  Int J Dev Neurosci       Date:  2010-10-08       Impact factor: 2.457

6.  Transcription factor TBX1 overexpression induces downregulation of proteins involved in retinoic acid metabolism: a comparative proteomic analysis.

Authors:  Marianna Caterino; Margherita Ruoppolo; Gabriella Fulcoli; Tuong Huynth; Stefania Orrù; Antonio Baldini; Francesco Salvatore
Journal:  J Proteome Res       Date:  2009-03       Impact factor: 4.466

7.  Enamel-free teeth: Tbx1 deletion affects amelogenesis in rodent incisors.

Authors:  Javier Catón; Hans-Ulrich Luder; Maria Zoupa; Matthew Bradman; Gilles Bluteau; Abigail S Tucker; Ophir Klein; Thimios A Mitsiadis
Journal:  Dev Biol       Date:  2009-02-20       Impact factor: 3.582

8.  The Neuroanatomy of Autism Spectrum Disorder Symptomatology in 22q11.2 Deletion Syndrome.

Authors:  M Gudbrandsen; E Daly; C M Murphy; R H Wichers; V Stoencheva; E Perry; D Andrews; C E Blackmore; M Rogdaki; L Kushan; C E Bearden; D G M Murphy; M C Craig; C Ecker
Journal:  Cereb Cortex       Date:  2019-07-22       Impact factor: 5.357

9.  Association of hypocalcemia with congenital heart disease in 22q11.2 deletion syndrome.

Authors:  Arpana Rayannavar; Lorraine E Levitt Katz; Terrence Blaine Crowley; Megan Lessig; Katheryn Grand; Elizabeth Goldmuntz; Elaine H Zackai; Donna M McDonald-McGinn
Journal:  Am J Med Genet A       Date:  2018-10-01       Impact factor: 2.802

10.  Murine model indicates 22q11.2 signaling adaptor CRKL is a dosage-sensitive regulator of genitourinary development.

Authors:  Meade Haller; Qianxing Mo; Akira Imamoto; Dolores J Lamb
Journal:  Proc Natl Acad Sci U S A       Date:  2017-04-24       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.